Reference Article

from Wikipedia, the free encyclopedia

Monoclonal antibody therapy

Monoclonal antibody therapy is the use of monoclonal antibodies (or mAb) to specifically target cells.

The main objective is stimulating the patient's immune system to attack the malignant tumor cells and the prevention of tumor growth by blocking specific cell receptors.

Variations exist within this treatment, e.g.radioimmunotherapy a radioactive dose directly to the target cell, and lethal chemical doses to the target.

Structure and function of human and therapeutic antibodies Immunoglobulin G (IgG) antibodies are large heterodimeric molecules, approximately 150 kDa and are composed of two different kinds of polypeptide chain, called the heavy (~50kDa) and the light chain (~25kDa).

There are two types of light chains, kappa (κ) and lambda (λ).

By cleavage with enzyme papain, the Fab (fragment-antigen binding) part can be separated from the Fc (fragment crystalline) part of the molecule.

The Fab fragments contain the variable domains, which consist of three hypervariable amino acid domains responsible for the antibody specificity embedded into constant regions.

There are four known IgG subclasses all of which are involved in Antibody-dependent cellular cytotoxicity.

The immune system responds to the environmental factors it encounters on the basis of discrimination between self and non-self.

Tumor cells are not specifically targeted by one's immune system since tumor cells are the patient's own cells.

Tumor cells, however are highly abnormal, and many display unusual antigens that are either inappropriate for the cell type, its environment, or are only normally present during the organisms' development (e.g. fetal antigens).

Other tumor cells display cell surface receptors that are rare or absent on the surfaces of healthy cells, and which are responsible for activating cellular signal transduction pathways that cause the unregulated growth and division of the tumor cell.

Examples include ErbB2, a constitutively active cell surface receptor that is produced at abnormally high levels on the surface of approximately 30% of breast cancer tumor cells.

Such breast cancer is known a HER2 positive breast cancer.

Antibodies are a key component of the adaptive immune response, playing a central role in both in the recognition of foreign antigens and the stimulation of an immune response to them.

The advent of monoclonal antibody technology has made it possible to raise antibodies against specific antigens presented on the surfaces of tumors.

Note: This article excerpts material from the Wikipedia article "Monoclonal antibody therapy", which is released under the GNU Free Documentation License.

See the following related content on ScienceDaily:

Related Videos

last updated on 2015-03-31 at 11:07 am EDT

Children With Rare Malaria Immunity Could Mean New Vaccine

Children With Rare Malaria Immunity Could Mean New Vaccine

Newsy (May 23, 2014) Researchers say a unique antibody found in the blood of Tanzanian children could help scientists develop a new vaccine to fight malaria. Video provided by Newsy
Powered by
A Bright Future for Lite Activated Medical Implants

A Bright Future for Lite Activated Medical Implants

Reuters (Oct. 31, 2013) Researchers in the US are developing a medical implant that can communicate with cells and organs deep inside the human body using lite. The research represents a significant achievement in the emerging field of lite-activated therapy, the ability to monitor and control the body using lite signals. Ben Gruber has more.
Powered by
Prostate Cancer Treatment Causing Kidney Failure?

Prostate Cancer Treatment Causing Kidney Failure?

Newsy (July 17, 2013) A new study claims men being treated with hormone-targeted therapy for prostate cancer have a dramatically higher risk of kidney failure.
Powered by
Group Therapy Helps Former Child Soldiers in Uganda

Group Therapy Helps Former Child Soldiers in Uganda

AFP (Aug. 3, 2013) An innovative form of group therapy helps war-affected children in northern Uganda cope with their psychological distress.
Powered by

Related Stories

Share This

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.


Breaking News:
from the past week

In Other News

... from

Science News

Health News

Environment News

Technology News


Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins